19-41012868-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000767.5(CYP2B6):​c.1294+53C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.26 in 1,599,590 control chromosomes in the GnomAD database, including 56,517 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6695 hom., cov: 32)
Exomes 𝑓: 0.26 ( 49822 hom. )

Consequence

CYP2B6
NM_000767.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.47

Publications

61 publications found
Variant links:
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.368 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000767.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2B6
NM_000767.5
MANE Select
c.1294+53C>T
intron
N/ANP_000758.1P20813-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2B6
ENST00000324071.10
TSL:1 MANE Select
c.1294+53C>T
intron
N/AENSP00000324648.2P20813-1
CYP2B6
ENST00000597612.1
TSL:1
n.647+383C>T
intron
N/A
CYP2B6
ENST00000863358.1
c.949+53C>T
intron
N/AENSP00000533417.1

Frequencies

GnomAD3 genomes
AF:
0.287
AC:
43621
AN:
151746
Hom.:
6695
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.373
Gnomad AMI
AF:
0.108
Gnomad AMR
AF:
0.341
Gnomad ASJ
AF:
0.263
Gnomad EAS
AF:
0.209
Gnomad SAS
AF:
0.380
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.241
Gnomad OTH
AF:
0.299
GnomAD4 exome
AF:
0.257
AC:
371755
AN:
1447726
Hom.:
49822
Cov.:
27
AF XY:
0.261
AC XY:
187923
AN XY:
721130
show subpopulations
African (AFR)
AF:
0.388
AC:
12828
AN:
33076
American (AMR)
AF:
0.320
AC:
14288
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
6970
AN:
26080
East Asian (EAS)
AF:
0.191
AC:
7591
AN:
39646
South Asian (SAS)
AF:
0.389
AC:
33437
AN:
85948
European-Finnish (FIN)
AF:
0.196
AC:
10266
AN:
52314
Middle Eastern (MID)
AF:
0.279
AC:
1604
AN:
5742
European-Non Finnish (NFE)
AF:
0.244
AC:
268969
AN:
1100300
Other (OTH)
AF:
0.264
AC:
15802
AN:
59944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
14943
29886
44828
59771
74714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9296
18592
27888
37184
46480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.287
AC:
43638
AN:
151864
Hom.:
6695
Cov.:
32
AF XY:
0.287
AC XY:
21309
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.373
AC:
15394
AN:
41318
American (AMR)
AF:
0.341
AC:
5198
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
914
AN:
3470
East Asian (EAS)
AF:
0.208
AC:
1071
AN:
5160
South Asian (SAS)
AF:
0.377
AC:
1818
AN:
4816
European-Finnish (FIN)
AF:
0.191
AC:
2021
AN:
10584
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.241
AC:
16399
AN:
67950
Other (OTH)
AF:
0.302
AC:
638
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1529
3059
4588
6118
7647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.263
Hom.:
17961
Bravo
AF:
0.298
Asia WGS
AF:
0.317
AC:
1100
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.084
DANN
Benign
0.62
PhyloP100
-2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8192719; hg19: chr19-41518773; COSMIC: COSV57842894; API